Mustapha Gidado

Executive Director

Gidado Mustapha is a Public Health Physician with over 16 years of experience in both clinical and programmatic management of Tuberculosis, Leprosy & HIV. His experience is at various levels and settings from clinic, regional, national and international levels, on program design, planning, implementation and monitoring and evaluation.

His major areas of competencies include program leadership and management, general TB & TB/HIV, PMDT, TB infection control & human resource development. He is a faculty member to two Nigeria Universities and Harvard School of Public Health (Executive Continuous Medical Education on TB infection Control) and KNCV Country Representative for KNCV and Challenge TB Country Director Nigeria.

In August 2020 Gidado Mustapha took up the position of Executive Director of KNCV Tuberculosis Foundation. He succeeded Kitty van Weezenbeek, who switched to the World Health Organization (WHO) on 1st May. Gidado was Interim Director for the last three months.

Gidado: “I’ve always worked in TB control. As a doctor, I have experienced firsthand that people and children died unnecessarily because they did not receive the correct treatment or because TB was discovered too late. That motivates me for this work. We are obliged to prevent this from continuing. I am honored and feel humble to be leading this organization in its mission, a world free of TB.”

Recent publications


Mitchell EMH, Adejumo OA, Abdur-Razza H, Ogbudebe C, Gidado M et al. Hybrid Approach to Estimation of Underreporting of Tuberculosis Case Notification in High- Burden Settings With Weak Surveillance Infrastructure: Design and Implementation of an Inventory Study. JMIR Public Health Surveill 2021 (7)| iss. 3 | e22352. Abstract

Onazi O, Adejumo AO, Redwood L, Gidado M, Daniel OJ, Mitchell EMH. et al. Community health care workers in pursuit of TB: Discourses and dilemmas. Soc Sci Med. 2020;246:112756. Abstract

Adejumo OA, Olusola-Faleye B, Adepoju VA, Gidado M, Onoh MO, Adegboye O, et al. The pattern of comorbidity and its prevalence among drug-resistant tuberculosis patients at treatment initiation in Lagos, Nigeria. Trans R Soc Trop Med Hyg. 2020;114(6):415-423. Abstract


read all the KNCV publications

KNCV has been fighting TB since its establishment in 1903. Over the past 120 years, the organization has acquired indispensable knowledge and experience in the field of effective TB prevention and care, resulting in pre-elimination in the Netherlands and significant contributions to global evidence generation, policy development and TB program implementation worldwide.

Our experts
KNCV governance framework and integrity
Our patroness
Partner with us

Tuberculosis is still one of the major causes of preventable death in the world and claims over 4000 lives a day, leading to over 1,5 million deaths a year.

Patient stories

The story of Abdurahim
The story of Fikeraddis
The story of Issayas
The story of Zarina
The story of Maxine
The story of Saanvi


De versie van de browser die je gebruikt is verouderd en wordt niet ondersteund.
Upgrade je browser om de website optimaal te gebruiken.